These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Resolution of oral hairy leukoplakia during treatment with foscarnet. Albrecht H; Stellbrink HJ; Brewster D; Greten H AIDS; 1994 Jul; 8(7):1014-6. PubMed ID: 7946089 [No Abstract] [Full Text] [Related]
5. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir. Jabs DA Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191 [TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus retinitis: new developments in prophylaxis and therapy. Jacobson MA AIDS Clin Rev; 1997-1998; ():249-69. PubMed ID: 9305451 [No Abstract] [Full Text] [Related]
7. Ganciclovir resistance: a matter of time and titre. Drew WL Lancet; 2000 Aug; 356(9230):609-10. PubMed ID: 10968428 [No Abstract] [Full Text] [Related]
8. Advances in treatment for cytomegalovirus retinitis. Bowers M BETA; 1995 Sep; ():13-5. PubMed ID: 11362885 [TBL] [Abstract][Full Text] [Related]
9. Identification of crystals in kidneys of AIDS patients treated with foscarnet. Maurice-Estepa L; Daudon M; Katlama C; Jouanneau C; Sazdovitch V; Lacour B; Beaufils H Am J Kidney Dis; 1998 Sep; 32(3):392-400. PubMed ID: 9740154 [TBL] [Abstract][Full Text] [Related]
10. Support for new foscarnet indication for AIDS-related CMV retinitis is mixed. AIDS Patient Care STDS; 1997 Oct; 11(5):377. PubMed ID: 11361828 [No Abstract] [Full Text] [Related]
11. Severe renal failure and polyneuritis induced by foscarnet. Chatelain E; Deminière C; Lacut JY; Potaux L Nephrol Dial Transplant; 1998 Sep; 13(9):2368-9. PubMed ID: 9761526 [No Abstract] [Full Text] [Related]
12. Transient foscarnet-induced hypercalcaemia. Barba R; Gómez-Rodrigo J; Marco J; Espejo M; Mena D AIDS; 1998 Oct; 12(14):1930-1. PubMed ID: 9792397 [No Abstract] [Full Text] [Related]
13. New treatment options for CMV retinitis in AIDS. Lalezari JP Adv Nurse Pract; 1997 Apr; 5(4):45-9, 83. PubMed ID: 9459896 [No Abstract] [Full Text] [Related]
14. Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir. Mueller AJ; Jacobson MA; Hurwitz S; Chuang EL; Friedberg DN; Haidt SJ; Heinemann MH; Jabs DA; Kaplan HJ; Freeman WR AIDS; 1997 Mar; 11(3):397-9. PubMed ID: 9147441 [No Abstract] [Full Text] [Related]
16. FDA notifications. FDA approves generic foscarnet sodium injection. AIDS Alert; 2005 Jul; 20(7):82. PubMed ID: 16110563 [No Abstract] [Full Text] [Related]
17. [Current status of the management of cytomegalovirus retinitis in patients with AIDS]. López-Cortés LF; Pachón-Díaz J Enferm Infecc Microbiol Clin; 1996 Mar; 14(3):137-41. PubMed ID: 8695680 [No Abstract] [Full Text] [Related]
18. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome. Guembel HO; Hofmann F; van Even G; Cinatl J; Makabe R Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542 [No Abstract] [Full Text] [Related]
19. [Mechanisms of antiviral resistance among the herpesvirus group]. Reina J Enferm Infecc Microbiol Clin; 1997; 15(6):329-34. PubMed ID: 9376408 [No Abstract] [Full Text] [Related]
20. A brighter future for the AIDS patient. Lowell E; Van Tassell B Insight; 2002; 27(4):95-6. PubMed ID: 12520982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]